Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple

Sexuality Clinical Trial

— SEXODON  

Official title:

Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03132818
• Other study ID #: RNI2016-25 Dr Scheffler
• Status: Withdrawn
• Start date: July 20, 2017
• Est. completion date: February 20, 2019

Study information

• Verified date: July 2020
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Sexual disorders associated with medical aid for procreation have already been demonstrated in several studies. However, few of them are interested in the problem of patients in charge of donating gametes, and if studied, it is often restricted to donating sperm to a small number of patients. For this reason, it would be interesting to study the impact of the intake and in charge and the treatments of the Medical Aid to the Procreation on this population of patients (including the patients treated in donation of sperm but also Those supported in oocyte donation)

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: February 20, 2019
• Est. primary completion date: February 20, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Couple, male and female, meeting the legal criteria for access to medically assisted procreation: a couple, a woman under the age of 43, who can testify to a life together. Then breakdown into 3 inclusion groups:

• Group 1: Patients undergoing AMP with oocyte donation

• Group 2: couples supported in AMP with sperm donation

• Group 3: torque supported in intra torque AMP.

Exclusion Criteria:

• Patients who do not meet the legal criteria for access to the MPA.

• Patients in charge of Medical Assistance for Procreation "Viral Risk"

• Patients undergoing medical aid for procreation for pre-existing sexual dysfunction.

• Patients awaiting embryo reception.

Related Conditions & MeSH terms

• Sexuality

Intervention

Other:
• To evaluate the prevalence of sexual disorders in patients receiving AMP
To evaluate the prevalence of sexual disorders in patients receiving AMP

Locations

Country	Name	City	State
France	CHU Amiens Picardie	Amiens	Picardie

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analysis of anonymous sexual well-being questionnaires: one reserved for men, another reserved for women	Analysis of anonymous sexual well-being questionnaires: one reserved for men, another reserved for women	1 year